Maternal Immunization

被引：101

作者：

Chu, Helen Y. ^{[1
]}

Englund, Janet A. ^{[2
]}

机构：

[1] Univ Washington, Dept Med, Div Allergy & Infect Dis, Washington, DC USA

[2] Seattle Childrens Hosp, Div Infect Dis, Dept Pediat, Washington, DC USA

来源：

CLINICAL INFECTIOUS DISEASES | 2014年 / 59卷 / 04期

基金：

美国国家卫生研究院;

关键词：

maternal immunization; influenza; tetanus; diphtheria; pertussis; INFLUENZAE TYPE-B; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; SYNCYTIAL VIRUS-INFECTION; PERTUSSIS TDAP IMMUNIZATION; PROTEIN CONJUGATE VACCINE; PREGNANT-WOMEN; ADVISORY-COMMITTEE; NEONATAL OUTCOMES; H1N1; INFLUENZA; PRACTICES ACIP;

D O I：

10.1093/cid/ciu327

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Maternal immunization has the potential to protect the pregnant woman, fetus, and infant from vaccine-preventable diseases. Maternal immunoglobulin G is actively transported across the placenta, providing passive immunity to the neonate and infant prior to the infant's ability to respond to vaccines. Currently inactivated influenza, tetanus toxoid, and acellular pertussis vaccines are recommended during pregnancy. Several other vaccines have been studied in pregnancy and found to be safe and immunogenic and to provide antibody to infants. These include pneumococcus, group B Streptococcus, Haemophilus influenzae type b, and meningococcus vaccines. Other vaccines in development for potential maternal immunization include respiratory syncytial virus, herpes simplex virus, and cytomegalovirus vaccines.

引用

页码：560 / 568

页数：9

共 73 条

[1] Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies [J].

Adegbola, Richard ;

Nesin, Mirjana ;

Wairagkar, Niteen .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 207 (03) :S28-S32

[2] Prevention of Maternal-Fetal Transmission of Cytomegalovirus [J].

Adler, Stuart P. ;

Nigro, Giovanni .

CLINICAL INFECTIOUS DISEASES, 2013, 57 :S189-S192

[3] Strategic priorities for respiratory syncytial virus (RSV) vaccine development [J].

Anderson, L. J. ;

Dormitzer, P. R. ;

Nokes, D. J. ;

Rappuoli, R. ;

Roca, A. ;

Graham, B. S. .

VACCINE, 2013, 31 :B209-B215

[4]

Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P1424

[5] Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine [J].

Baker, CJ ;

Rench, MA ;

McInnes, P .

VACCINE, 2003, 21 (24) :3468-3472

[6] Safety Data on Meningococcal Polysaccharide Vaccine from the Vaccine Adverse Event Reporting System [J].

Ball, R ;

Braun, MM ;

Mootrey, GT .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) :1273-1280

[7] Efficacy Results of a Trial of a Herpes Simplex Vaccine [J].

Belshe, Robert B. ;

Leone, Peter A. ;

Bernstein, David I. ;

Wald, Anna ;

Levin, Myron J. ;

Stapleton, Jack T. ;

Gorfinkel, Iris ;

Morrow, Rhoda L. Ashley ;

Ewell, Marian G. ;

Stokes-Riner, Abbie ;

Dubin, Gary ;

Heineman, Thomas C. ;

Schulte, Joann M. ;

Deal, Carolyn D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01) :34-43

[8] Haemophilus influenzae type b immunization in infants in the United Kingdom:: Effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose [J].

Berrington, JE ;

Cant, AJ ;

Matthews, JNS ;

O'Keeffe, M ;

Spickett, GP ;

Fenton, AC .

PEDIATRICS, 2006, 117 (04) :E717-E724

[9]

Bridges CB, 2013, MMWR-MORBID MORTAL W, V62, P9

[10]

BROWN GC, 1958, J IMMUNOL, V81, P389

← 1 2 3 4 5 6 7 8 →